You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Albumin-Bound Paclitaxel

Showing 1 - 25 of 4,227
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ovarian Carcinoma, Platinum-resistant Ovarian Cancer, Recurrent Ovarian Carcinoma Trial in Beijing (Albumin-bound paclitaxel and

Recruiting
  • Ovarian Carcinoma
  • +6 more
  • Albumin-bound paclitaxel and bevacizumab
  • Beijing, Beijing, China
    Lei Li
Mar 26, 2022

Breast Cancer Trial in Beijing (doxorubicin, epirubicin, pirarubicin)

Not yet recruiting
  • Breast Cancer
  • Beijing, Beijing, China
    Cancer Hospital, ChineseAMS
Mar 17, 2022

Ovarian Cancer Trial (albumin-bound paclitaxel, paclitaxel)

Not yet recruiting
  • Ovarian Cancer
  • (no location specified)
Mar 31, 2022

Locally Advanced Pancreatic Cancer Trial in Shanghai (Tumor treating fields combined with Gemcitabine HCl and albumin binding

Not yet recruiting
  • Locally Advanced Pancreatic Cancer
  • Tumor treating fields combined with Gemcitabine hydrochloride and albumin binding paclitaxel
  • Gemcitabine hydrochloride and albumin binding paclitaxel
  • Shanghai, Shanghai, China
    Huashan Hospital Affiliated to Fudan University
Dec 8, 2022

Breast Cancer Trial in Beijing (Inetetamab, Toripalimab, Albumin-Bound Paclitaxel)

Not yet recruiting
  • Breast Cancer
  • Beijing, China
    Cancer Hospital Chinese Academy Of Medical Sciences
Mar 14, 2022

Advanced Urothelial Carcinoma Trial in Beijing (anti-PD-L1 antibody, albumin bound paclitaxel)

Active, not recruiting
  • Advanced Urothelial Carcinoma
  • anti-PD-L1 antibody
  • albumin bound paclitaxel
  • Beijing, Beijing, China
    Beijing Tumor Hospital
Jan 20, 2022

Triple-negative Breast Cancer Trial in Bengbu (Albumin-Bound Paclitaxel, Apatinib Mesylate, Bevacizumab)

Recruiting
  • Triple-negative Breast Cancer
  • Albumin-Bound Paclitaxel
  • +2 more
  • Bengbu, Anhui, China
    Department of Medical Oncology, First Affiliated Hospital of Ben
Mar 15, 2022

Soft Tissue Sarcoma Trial in Zhengzhou (Albumin-Bound Paclitaxel, Camrelizumab)

Recruiting
  • Soft Tissue Sarcoma
  • Zhengzhou, Henan, China
    Department of Bone and Soft Tissue, Henan Cancer Hospital
Jan 13, 2022

Solid Tumor, Adult Trial (EOC202, albumin-bound paclitaxel)

Not yet recruiting
  • Solid Tumor, Adult
  • EOC202
  • albumin-bound paclitaxel
  • (no location specified)
Apr 7, 2022

Pancreatic Cancer Trial in Tianjin (albumin-bound paclitaxel)

Recruiting
  • Pancreatic Cancer
  • albumin-bound paclitaxel
  • Tianjin, Tianjin, China
    Rui Liu
Sep 14, 2021

Recurrent Cervical Carcinoma, Persistent Advanced Cervical Carcinoma, Chemo Trial in Beijing (Anti-PD-1 antibody camrelizumab,

Recruiting
  • Recurrent Cervical Carcinoma
  • +5 more
  • Anti-PD-1 antibody camrelizumab
  • Albumin-bound paclitaxel
  • Beijing, Beijing, China
    Lei Li
Mar 12, 2022

Gastric Cancer Trial in Wuhan (Albumin-bound Paclitaxel plus S-1, Oxaliplatin plus S-1)

Recruiting
  • Gastric Cancer
  • Albumin-bound Paclitaxel plus S-1
  • Oxaliplatin plus S-1
  • Wuhan, Hubei, China
    Tongji hospital of Tongji Medical College, Huazhong University o
Jan 3, 2022

Head and Neck Squamous Cell Carcinoma Trial (Camrelizumab+Apatinib mesylate+Albumin-bound paclitaxel+cisplatin)

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Camrelizumab+Apatinib mesylate+Albumin-bound paclitaxel+cisplatin
  • (no location specified)
Dec 29, 2021

Gastric Cancer, GastroEsophageal Cancer Trial in Wuhan (Albumin-bound Paclitaxel Plus SHR-1210 (PD-1 inhibitor), Albumin-bound

Recruiting
  • Gastric Cancer
  • GastroEsophageal Cancer
  • Albumin-bound Paclitaxel Plus SHR-1210 (PD-1 inhibitor)
  • Albumin-bound Paclitaxel
  • Wuhan, Hubei, China
    Tongji hospital of Tongji Medical College, Huazhong University o
Feb 6, 2022

Advanced Triple Negative Breast Cancer Trial in Fuzhou (Apatinib Mesylate, Albumin-Bound Paclitaxel)

Not yet recruiting
  • Advanced Triple Negative Breast Cancer
  • Apatinib Mesylate
  • Albumin-Bound Paclitaxel
  • Fuzhou, Fujian, China
    Fujian Cancer Hospital
Aug 18, 2021

Cholangiocarcinoma Trial (Carrilizumab, Albumin-bound paclitaxel, Apatinib)

Not yet recruiting
  • Cholangiocarcinoma
  • (no location specified)
Dec 9, 2022

Angiosarcoma Metastatic Trial in Guangzhou (Abraxane combined with liposomal doxorubicin)

Recruiting
  • Angiosarcoma Metastatic
  • Abraxane combined with liposomal doxorubicin
  • Guangzhou, Guangdong, China
    Xing Zhang
Nov 15, 2021

Untreated Metastatic Pancreatic Ductal Adenocarcinoma Trial in Scottsdale (Nivolumab, Albumin-bound paclitaxel, Paricalcitol)

Active, not recruiting
  • Untreated Metastatic Pancreatic Ductal Adenocarcinoma
  • Scottsdale, Arizona
    HonorHealth Research Institute
Feb 15, 2022

Breast Cancer Trial in Chengdu (Pyrotinib combined with albumin-bound paclitaxel and trastuzumab)

Recruiting
  • Breast Cancer
  • Pyrotinib combined with albumin-bound paclitaxel and trastuzumab
  • Chengdu, Chengdu, Sichuan, China, China
    West China Hospital, Sichuan University
Sep 10, 2021

Pancreatic Cancer Trial in Tianjin (SHR-1020+albumin-bound paclitaxel)

Recruiting
  • Pancreatic Cancer
  • SHR-1020+albumin-bound paclitaxel
  • Tianjin, Tianjin, China
    Tianjin Medical University Cancer Institute and Hospital
May 21, 2021

Second Line Treatment of Gastric Cancer Trial (Camrelizumab, Albumin-Bound Paclitaxel, Irinotecan)

Not yet recruiting
  • Second Line Treatment of Gastric Cancer
  • (no location specified)
Dec 20, 2022

Advanced Pancreatic Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8 Trial in Atlanta

Recruiting
  • Advanced Pancreatic Adenocarcinoma
  • +2 more
  • Atlanta, Georgia
  • +2 more
Feb 28, 2022

Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Locally Advanced Triple-Negative Breast

Not yet recruiting
  • Anatomic Stage III Breast Cancer AJCC v8
  • +4 more
  • BET Bromodomain Inhibitor ZEN-3694
  • +3 more
  • (no location specified)
Jun 28, 2022

Breast Cancer Trial in China (Albumin-bound paclitaxel combined with carboplatin, Epirubicin combined with docetaxel)

Recruiting
  • Breast Cancer
  • Albumin-bound paclitaxel combined with carboplatin
  • Epirubicin combined with docetaxel
  • Harbin, Heilongjiang, China
  • +6 more
Jul 18, 2021

Head and Neck Squamous Cell Carcinoma, Neoadjuvant Treatment Trial in Zhuhai (Tislelizumab, Low-dose radiotherapy)

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Neoadjuvant Treatment
  • Zhuhai, Guangdong, China
    Fifth Affilliated Hospital of Sun Yat-sen University
Apr 22, 2022